Key takeaway: KO has slipped nearly 2% from its early-September high of $89.35, now…
Premium · Advanced plan
Read the full KO Stock Report on ORTEX
The full multi-page analysis — short-interest history, options flow, analyst movement, valuation, and outlook — is available on the Advanced plan in ORTEX.
Read full report on ORTEX →Previous versions
Coca-Cola Quietly Steadies as Q3 Approaches
Version 20Sep 7, 2026Coca-Cola: Shorts Exit as Analysts Chase Higher Targets
Version 18Aug 24, 2026KO Closes on the Street — But the Gap Is Nearly Gone
Version 17Aug 17, 2026KO Insiders Cashed Out at the Top. The Stock Held Anyway.
Version 16Aug 10, 2026KO Settles Into a Waiting Game at $87
Version 15Aug 3, 2026KO: The Q2 Euphoria Fades Into a Valuation Question
Version 14Jul 27, 2026KO's Q2 Clears the Bar — Now India Does the Heavy Lifting
Version 13Jul 20, 2026KO Fires India IPO Starter Gun, Eight Days Before the Q2 Print
Version 12Jul 13, 2026KO's Short Sellers Return — Eight Days Before the Print
Version 11Jul 6, 2026KO Hits All-Time High with Earnings 15 Days Away
Version 10Jun 29, 2026KO Bounces Back — Options Turn Bullish as July 21 Earnings Loom
Version 9Jun 22, 2026KO's Rally Fades — Options Traders Turn Cautious Before July Earnings
Version 8Jun 15, 2026Coca-Cola Grinds Higher as Bulls Take Over From the Bears
Version 7Jun 8, 2026Coca-Cola Shorts Retreat as India IPO Story Builds Pre-Q2
Version 6Jun 1, 2026Coca-Cola's Analyst Tide Lifts — But the CEO Is Selling Into It
Version 4May 18, 2026KO Closes the Gap on Analyst Targets After Wells Fargo Lifts to $90
Version 3May 11, 2026KO: Defensive Put Buying Persists as Short Cover Completes
Version 2May 4, 2026KO Beats Estimates, Shorts Retreat — Options Turn More Cautious
Version 1Apr 27, 2026Coca-Cola Heads Into Q1 Earnings With Shorts Retreating and Options Defense Rising
About ORTEX Stock Reports
Stock Reports are weekly long-form pieces written from ORTEX's own datasets — short interest, securities-lending, options flow, analyst movement, institutional positioning, valuation, and news — combined with the company's recent ORTEX coverage to keep the analysis consistent with what was published before.
Bodies are intentionally not available on ortex.news — the report is the headline Advanced-plan benefit. The opening is preserved here so readers can see which names are being covered each week.